Concepedia

John Replogle

JR

4

Publications

387

Citations

4

H-Index

2015

Active since

Affiliations

Massachusetts Institute of Technology(Current)

Broad Institute

Howard Hughes Medical Institute

Cold Spring Harbor Laboratory

Dana-Farber Cancer Institute

John Replogle is an author at Massachusetts Institute of Technology specializing in health sciences, drug resistance, and tumor heterogeneity.

Top concepts

Publications per year

2015–2021

4

Publications

4

Single-chromosome Gains Commonly Function as Tumor Suppressors

Jason M. Sheltzer, Julie H. Ko, John Replogle et al. · Cancer Cell · 2017 · 208 citations · Full text

Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division

John Replogle, Wen Zhou, Adrianna E. Amaro et al. · Proceedings of the National Academy of Sciences · 2020 · 109 citations · Full text

, , +16

<i>RAD21</i> is a driver of chromosome 8 gain in Ewing sarcoma to mitigate replication stress

Xiaofeng A. Su, Duanduan Ma, James V. Parsons et al. · Genes & Development · 2021 · 54 citations · Full text

A<i>cis</i>-regulatory antisense RNA represses translation in<i>Vibrio cholerae</i>through extensive complementarity and proximity to the target locus

Howard Chang, John Replogle, Naomi Vather et al. · RNA Biology · 2015 · 16 citations · Full text

Rows per page

1–4 of 4